Dissolved
CVR: 30564782
Not available
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 2 August 2011
CVR · view overview
2 employees
CVR · 2007
Director role ended: Jakob Mosegaard Larsen
CVR · 02/08/2011
View the full event history
SPREE PHARMA A/S was a Danish company of the type Aktieselskab based in København K, founded in 2007. The company has been dissolved on 2 August 2011. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2007).
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. SPREE PHARMA A/S is registered in the Danish CVR register with the status Dissolved and ceased on 2 August 2011.
The CVR number of SPREE PHARMA A/S is 30564782.
SPREE PHARMA A/S had 2 employees in 2007 according to the Danish CVR register.
SPREE PHARMA A/S was founded on 23 March 2007.
SPREE PHARMA A/S was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721900).
SPREE PHARMA A/S was located at c/o Nielsen Nørager, Frederiksberggade 16, 1459 København K.
As of August 2, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of SPREE PHARMA A/S.
As of August 2, 2011, Jakob Mosegaard Larsen has stepped down as liquidator of SPREE PHARMA A/S.
On August 2, 2011, SPREE PHARMA A/S exited liquidation.
SPREE PHARMA A/S was dissolved on August 2, 2011.
As of July 9, 2010, Wyle David Solomon has left the board of directors of SPREE PHARMA A/S.
As of July 9, 2010, osagie imasogie has left the board of directors of SPREE PHARMA A/S.
As of July 9, 2010, Mathew Callahan has left the board of directors of SPREE PHARMA A/S.
As of July 9, 2010, Jakob Mosegaard Larsen is registered as liquidator of SPREE PHARMA A/S.
As of July 9, 2010, Florian Schønharting has stepped down as chairman of SPREE PHARMA A/S.
As of July 9, 2010, Wyle David Solomon has stepped down as adm. dir of SPREE PHARMA A/S.
On July 9, 2010, SPREE PHARMA A/S entered liquidation.
As of July 8, 2009, Wyle David Solomon is registered as adm. dir of SPREE PHARMA A/S.
As of July 8, 2009, Christian Karsten Hansen has stepped down as adm. dir of SPREE PHARMA A/S.
As of May 18, 2009, Wyle David Solomon has joined the board of directors of SPREE PHARMA A/S.
As of May 18, 2009, Christian Karsten Hansen has left the board of directors of SPREE PHARMA A/S.
As of March 23, 2007, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of SPREE PHARMA A/S.
As of March 23, 2007, Christian Karsten Hansen has joined the board of directors of SPREE PHARMA A/S.
As of March 23, 2007, osagie imasogie has joined the board of directors of SPREE PHARMA A/S.
As of March 23, 2007, Mathew Callahan has joined the board of directors of SPREE PHARMA A/S.
As of March 23, 2007, Christian Karsten Hansen is registered as adm. dir of SPREE PHARMA A/S.
As of March 23, 2007, Florian Schønharting is registered as chairman of SPREE PHARMA A/S.
SPREE PHARMA A/S was founded on March 23, 2007.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
